1-13 of 13
Sarah M Larson
Close
Sort by
Journal Articles

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone (DIPD) As Salvage Therapy in Early Relapsed/Refractory Multiple Myeloma

Anupama Kumar, Aaron S. Rosenberg, Edward D. Ball, Sarah M. Larson, Lindsey Sirianni, Carolyn M. Mulroney, Caitlin L. Costello
Journal: Blood
Blood (2023) 142 (Supplement 1): 4750.
https://doi.org/10.1182/blood-2023-181091
Published: 2023
Journal Articles

A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Sarah M. Larson, Yvonne Y Chen, Jim Johnston, Sylvain Roy, Pinakin Patel, Jonathan E Benjamin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6892.
https://doi.org/10.1182/blood-2023-187614
Published: 2023
Journal Articles

Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access Protocol

Nizar J Bahlis, Suzanne Trudel, Christopher Maisel, Lisa X. Lee, Jorge Monge, Claudia Paba Prada, Sarah M. Larson, Guenther Koehne, Yogesh Jethava, Wei Dong Ma, Cristina De Nicolo, Isabel Perez-Cruz
Journal: Blood
Blood (2023) 142 (Supplement 1): 6737.
https://doi.org/10.1182/blood-2023-189700
Published: 2023
Journal Articles

Deliriogenic Medication Use in Older Adults Receiving CAR-T Correlates with Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Michael J. Maranzano, Justin Cheng, John Timmerman, Patricia A. Young, Caspian H. Oliai, Herbert A. Eradat, Sven de Vos, Sarah M. Larson, Monica Mead
Journal: Blood
Blood (2023) 142 (Supplement 1): 7358.
https://doi.org/10.1182/blood-2023-182105
Published: 2023
Journal Articles

Updated Follow-up of a Phase 1 Trial of Bispecific CART19/20 Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Benjamin R Puliafito, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin Harris, Mobina Khericha, Melanie Ayala Ceja, Christy Sidhu, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Karla Nawaly, Martin S Allen-Auerbach, Jonathan Said, Monica Mead, Sven de Vos, Patricia A. Young, Caspian H. Oliai, Gary J. Schiller, John Timmerman, Antoni Ribas, Yvonne Y Chen, Sarah M. Larson
Journal: Blood
Blood (2023) 142 (Supplement 1): 3490.
https://doi.org/10.1182/blood-2023-186636
Published: 2023
Journal Articles

Hematopoietic Cell Transplantation of Higher CD34+ Cell Doses and Specific CD34+ Subsets Mobilized with Motixafortide and/or G-CSF Is Associated with Rapid Engraftment - a Post-Hoc Analysis of the Genesis Trial

Zachary D. Crees, Keith E. Stockerl-Goldstein, Michael Retting, Sarah M Larson, Arpad Illes, Giuseppe Milone, Massimo Martino, Patrick Stiff, Douglas W. Sborov, Denise L. Pereira, Ivana N. Micallef, Gemma Moreno Jiménez, Gábor Mikala, Maria Liz Paciello Coronel, Udo Holtick, John W. Hiemenz, Muzaffar H. Qazilbash, Nancy M. Hardy, Tahir Latif, Irene García-Cadenas, Ella Sorani, Liron Shemesh-Darvish, Abi Vainstein, Shaul Kadosh, John F. DiPersio
Journal: Blood
Blood (2021) 138 (Supplement 1): 2849.
https://doi.org/10.1182/blood-2021-146783
Published: 2021
Journal Articles

Outcomes of Classical Hodgkin Lymphoma in US Hematology Practices: Initial Data from a Prospective Real-World Study

Christopher A. Yasenchak, MD, Jakub Svoboda, MD, Sarah M Larson, MD, Don A Stevens, MD, Srikanth Gajavelli, MD, Trong Kim Le, Philippe Armand, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5626.
https://doi.org/10.1182/blood.V130.Suppl_1.5626.5626
Published: 2017
Journal Articles

Inhibition of PI3K Alpha and PI3K Delta with Copanlisib Shows Preclinical Activity As a Single Agent and in Combination in Multiple Myeloma

Sarah M Larson, MD, Mao Yu Peng, PhD, Monica Mead, MD BS, Andrae Vandross, MD, Dylan Conklin, PhD, Erika Von Euw, PhD, Dennis J. Slamon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3084.
https://doi.org/10.1182/blood.V130.Suppl_1.3084.3084
Published: 2017
Journal Articles

Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)

Neil P. Shah, MD PhD, Jose Valentín García Gutiérrez, PhD, Antonio Jiménez-Velasco, MD, Sarah M Larson, MD, Susanne Saussele, MD, Delphine Rea, MD, François-Xavier Mahon, MD PhD, Moshe Levy, MD, María Teresa Gómez-Casares, MD PhD, Fabrizio Pane, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Oumar Sy, PhD, Patricia Martin-Regueira, MD, Jeffrey H. Lipton, PhD MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 314.
https://doi.org/10.1182/blood.V130.Suppl_1.314.314
Published: 2017
Journal Articles

Activity of the Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Copanlisib, As a Single Agent and in Combination with Carfilzomib in Multiple Myeloma

Sarah M Larson, MD, Mao Yu Peng, PhD, Andrae Vandross, MD, Monica Mead, MD BS, Zoe Fuchs, Dylan Conklin, PhD, Erika Von Euw, PhD BS, Dennis J. Slamon, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5665.
https://doi.org/10.1182/blood.V128.22.5665.5665
Published: 2016
Journal Articles

Systematic Comparison of the EF-1 Alpha Short (EFS) and Viral Promoters for Gene Modification of Human Primary Cells for Clinical Applications

Roy L. Kao, MD, Eric H. Gschweng, BS, Avigael Rebecca Lerman, Sarah M. Larson, MD, Andy Tu, Tulika Tyagi, MS, Shantha Senadheera, MS, Roger P. Hollis, PhD, Satiro N. De Oliveira, MD
Journal: Blood
Blood (2014) 124 (21): 3497.
https://doi.org/10.1182/blood.V124.21.3497.3497
Published: 2014
Journal Articles

Second-Generation Chimeric Antigen Receptors Successfully Modify Hematopoietic Stem Cells for Immunotherapy of B-Lineage Malignancies

Roy L. Kao, MD, Tulika Tyagi, MS, Sarah M. Larson, MD, Andy Tu, Shantha Senadheera, MS, Roger P. Hollis, PhD, Satiro N. De Oliveira, MD
Journal: Blood
Blood (2014) 124 (21): 655.
https://doi.org/10.1182/blood.V124.21.655.655
Published: 2014
Journal Articles

Anti-CD19 Chimeric Antigen Receptor Controlled By The Suicide Gene HSVsr39TK In Hematopoietic Stem Cells For Immunotherapy Of B-Lineage Malignancies

Sarah M. Larson, MD, Andy Tu, Shanta Senadheera, Michelle Ho, BS, Donald B. Kohn, MD, Satiro deOliveira, MD
Journal: Blood
Blood (2013) 122 (21): 1659.
https://doi.org/10.1182/blood.V122.21.1659.1659
Published: 2013